[Usefulness of 99mTc-DTPA-HSA scintigraphy in the diagnosis of protein losing enteropathy--comparison with 99mTc-HSA].
We evaluated the usefulness of 99mTc-diethylene-triamine-pentaacetic acid human serum albumin scintigraphy (FTPA-HSA) in the diagnosis of protein losing enteropathy in 3 cases of inflammatory bowel diseases in comparison with 99mTc-human serum albumin scintigraphy (HSA). The results were as follows: 1. DTPA-HSA demonstrated the colonic accumulation earlier than that of HSA. 2. Hepatic flexure and splenic flexure are not observed clearly, because of marked renal uptake in HSA. On the other hand, they are observed in DTPA-HSA. Hepatic uptake is rather stronger in DTPA-HSA. In conclusion, DTPA-HSA is one of the easiest and most useful methods in the diagnosis of protein losing enteropathy.
Sato
T
T
Department of Radiology, Hiroshima University School of Medicine.
Nakanishi
T
T
Taniguchi
K
K
Ito
K
K
D000328:Adult; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D011504:Protein-Losing Enteropathies / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013668:Technetium Tc 99m Aggregated Albumin / Q000592:standards; D016284:Technetium Tc 99m Pentetate / Q000592:standards
D013668:Technetium Tc 99m Aggregated Albumin; C057162:technetium Tc 99m DTPA HSA; D016284:Technetium Tc 99m Pentetate